Document is current
Any future updates will be listed below
-
Authors
Sultan, Hussein http://orcid.org/0000-0003-4067-8169
Takeuchi, Yoshiko http://orcid.org/0000-0002-2637-7696
Ward, Jeffrey P. http://orcid.org/0000-0002-9707-895X
Sharma, Naveen http://orcid.org/0000-0002-1343-3230
Liu, Tian-Tian http://orcid.org/0000-0001-9377-9938
Sukhov, Vladimir
Firulyova, Maria
Song, Yuang
Ameh, Samuel
Brioschi, Simone
Khantakova, Darya http://orcid.org/0000-0002-2579-5140
Arthur, Cora D.
White, J. Michael http://orcid.org/0000-0001-5110-6567
Kohlmiller, Heather
Salazar, Andres M.
Burns, Robert
Costa, Helio A.
Moynihan, Kelly D.
Yeung, Yik Andy
Djuretic, Ivana
Schumacher, Ton N.
Sheehan, Kathleen C. F.
Colonna, Marco http://orcid.org/0000-0001-5222-4987
Allison, James P.
Murphy, Kenneth M. http://orcid.org/0000-0002-3505-9630
Artyomov, Maxim N. http://orcid.org/0000-0002-1133-4212
Schreiber, Robert D. http://orcid.org/0000-0003-1590-2341
- License Information
-
More Information
Article History
Received: 28 October 2022
Accepted: 25 June 2024
First Online: 24 July 2024
Competing interests
: R.D.S. is a cofounder, scientific advisory board member, stockholder and royalty recipient of Asher Biotherapeutics, and is a paid scientific advisory board member for A2 Biotherapeutics, NGM Biopharmaceuticals, BioLegend, Sensei Biotherapeutics Neuvogen and BlueSphere Biopharmaceuticals. K.M.M. is on the Scientific Advisory Board for Harbour Biomed. J.P.A. receives consulting fees from Achelois, Adaptive Biotechnologies, Apricity, BioAtla, BioNTech, Candel Therapeutics, Codiak, Dragonfly, Earli, Enable Medicine, Hummingbird, ImaginAb, Jounce, Lava Therapeutics, Lytix, Marker, PBM Capital, Phenomic AI, Polaris Pharma, Time Bioventures, Trained Therapeutix, Two Bear Capital and Venn Biosciences; and has ownership of stocks for Achelois, Adaptive Biotechnologies, Apricity, BioAtla, BioNTech, Candel Therapeutics, Codiak, Dragonfly, Earli, Enable Medicine, Hummingbird, ImaginAb, Jounce, Lava Therapeutics, Lytix, Marker, PBM Capital, Phenomic AI, Polaris Pharma, Time Bioventures, Trained Therapeutix, Two Bear Capital and Venn Biosciences. T.N.S. is a cofounder, scientific advisory board member and stockholder of Asher Biotherapeutics and Neogene Therapeutics, cofounder and stockholder of Cell Control Bio, consultant and stockholder at Third Rock Ventures, and a scientific advisory board member for Allogene Therapeutics, Celsius, Merus and Scenic Biotech. K.D.M., Y.A.Y. and I.D. are full-time employees of Asher Biotherapeutics. R.B. and H.A.C. are full-time employees of Natera, Inc. All other authors declare no competing interests.
